Browse the corpus

Disopyramide is an antiarrhythmic medication predominantly used in the management of ventricular arrhythmias, particularly in cases of sustained ventricular tachycardia or atrial fibrillation. Classified as a Class Ia agent, it acts by blocking sodium channels, thereby decreasing excitability and conduction velocity in cardiac tissue. The medication needs careful dosage adjustments, especially in patients with conditions such as renal impairment or heart failure. Disopyramide is less commonly used than other antiarrhythmics because of its adverse effects, such as anticholinergic effects, including dry mouth and constipation. A thorough understanding of its pharmacology, appropriate usage, and potential complications is crucial for healthcare providers to optimize patient care. Continuous monitoring and thorough patient assessment can help mitigate risks associated with disopyramide therapy, ensuring that its benefits in restoring regular heart rhythm outweigh the potential adverse effects. This activity focuses on the indications, mechanism of action, administration, adverse events, contraindications, monitoring, and toxicity of the medication. This activity is designed to provide essential knowledge and practical tools for the effective administration of disopyramide. This activity emphasizes the critical role of the interprofessional healthcare team in managing disopyramide therapy. The activity empowers healthcare professionals to make informed, evidence-based decisions that enhance patient care and lead to the best possible outcomes. This activity focuses on methods to minimize adverse reactions and enhance the effectiveness of disopyramide. This activity equips healthcare professionals with the knowledge to deliver safe, effective, and personalized care during disopyramide treatment, thereby improving patient outcomes. Objectives: Evaluate the mechanism of action of disopyramide. Assess the potential adverse effects of disopyramide. Identify the Food and Drug Administration–approved indications of disopyramide. Implement interprofessional team strategies to improve care coordination and communication when using disopyramide, thereby maximizing the benefits of this medication and minimizing its adverse effects. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose The safe therapeutic disopyramide concentrations range from 2 to 5 mg/mL. Notably, in patients with cirrhosis, lower concentrations are preferable due to increased free form.[44] Toxic signs and symptoms of disopyramide typically occur when plasma concentrations exceed 7mg/mL.[45][46][47] Accidental or intentional overdose of oral disopyramide may lead to serious complications, including apnea, loss of consciousness, cardiac arrhythmias, and respiratory arrest. Fatal outcomes have been reported. Toxic plasma concentrations are associated with marked QRS and QTc prolongation, exacerbation of heart failure, hypotension, bradycardia, conduction abnormalities, and progression to asystole. Management of Overdose Due to its relatively small volume of distribution (Vd), low protein binding at toxic concentrations, and low intrinsic clearance, extracorporeal drug removal techniques (hemoperfusion or hemodialysis) can help remove disopyramide from the circulation in cases of intoxication.[48]

The safe therapeutic disopyramide concentrations range from 2 to 5 mg/mL. Notably, in patients with cirrhosis, lower concentrations are preferable due to increased free form.[44] Toxic signs and symptoms of disopyramide typically occur when plasma concentrations exceed 7mg/mL.[45][46][47] Accidental or intentional overdose of oral disopyramide may lead to serious complications, including apnea, loss of consciousness, cardiac arrhythmias, and respiratory arrest. Fatal outcomes have been reported. Toxic plasma concentrations are associated with marked QRS and QTc prolongation, exacerbation of heart failure, hypotension, bradycardia, conduction abnormalities, and progression to asystole. Management of Overdose Due to its relatively small volume of distribution (Vd), low protein binding at toxic concentrations, and low intrinsic clearance, extracorporeal drug removal techniques (hemoperfusion or hemodialysis) can help remove disopyramide from the circulation in cases of intoxication.[48] Generally, the initial priority is to decontaminate the patient's gastrointestinal system through lavage and repeat doses of oral activated charcoal. These effects are observed even when several hours have passed since the first ingestion, as it can significantly delay the absorption of class Ia antiarrhythmics. The patient should then be admitted to an intensive care unit for continuous electrocardiographic monitoring. Hemodialysis or hemoperfusion can be helpful if the patient has ingested large doses or has a high drug concentration, or in the setting of circulatory collapse or renal insufficiency. Symptomatic drugs should be given accordingly. For seizures, administration of benzodiazepines can be helpful. In hypotensive patients, fluid challenges and intravenous inotropic and vasopressor agents should be used. Mechanical supports, such as intra-aortic balloon pumps or cardiopulmonary bypass, should be considered in cases of refractory cardiogenic shock. Lastly, in the setting of arrhythmia, whether it is bradyarrhythmia or ventricular tachycardia (torsade de pointes), the appropriate medication should be given. Although based only on theoretical considerations, NaHCO3 (50 mmol) can be given intravenously and repeated every 5 to 10 minutes. The primary goal is to maintain an arterial pH of 7.4 to 7.5. The drug reversal mechanism is likely multifactorial, involving increases in blood pH, blood plasma sodium concentration, and a decrease in plasma potassium concentration.[30]

To enhance patient-centered care, outcomes, patient safety, and team performance related to disopyramide, it is essential for healthcare professionals, including clinicians, advanced practitioners, nurses, pharmacists, and other team members, to cultivate a diverse set of skills and strategies. Key competencies include strong clinical assessment skills to closely monitor patients for potential adverse effects and effective interprofessional communication to ensure coordinated care. Ethical considerations, such as respecting patient autonomy and adhering to the principles of beneficence and non-maleficence, are fundamental in fostering trust and ensuring that patients are informed about their treatment options.[49] Each member of the healthcare team has specific responsibilities, from medication management to patient education, which are critical in managing the complexities of disopyramide therapy. Regular interdisciplinary meetings, shared electronic health records, and clear documentation practices help strengthen care coordination, enabling a comprehensive approach to managing treatment and minimizing risks. The use of disopyramide is already approved by several clinical guidelines, including those of the Heart Rhythm Society, the American Heart Association, the American College of Cardiology, and the European Heart Rhythm Association (EHRA). Disopyramide is indicated as a third-line agent for the treatment of life-threatening arrhythmias (ventricular arrhythmias) and atrial fibrillation, especially sleep-induced or vagal-induced.[32][16][33] Disopyramide can also be used in hypertrophic obstructive cardiomyopathy in combination with beta-blockers.[9] Ultimately, a collaborative and patient-centric framework between clinicians, advanced practice providers, pharmacists, and nurses ensures that healthcare teams are equipped to provide high-quality care, improve outcomes, and maintain patient safety throughout the treatment process.